Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31157579

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Aug 20
First author
Lin JK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Aug 20;37(24):2095-2097. doi: 10.1200/JCO.19.01113.
    note
    Source null
    related pmid
    31157580
    relationship
    Comment in

Authors and identifiers

  1. name
    Lin JK
    type
    Author
  2. name
    Muffly LS
    type
    Author
  3. name
    Spinner MA
    type
    Author
  4. name
    Barnes JI
    type
    Author
  5. name
    Owens DK
    type
    Author
  6. name
    Goldhaber-Fiebert JD
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lin JK
    type
    Author
  2. name
    Muffly LS
    type
    Author
  3. name
    Spinner MA
    type
    Author
  4. name
    Barnes JI
    type
    Author
  5. name
    Owens DK
    type
    Author
  6. name
    Goldhaber-Fiebert JD
    type
    Author
bibliography ids
  1. nci-bib-4e6654d0287e66e106fad343
book metadata
content sha256
363034fbc311776b294e529540528e86dff0e83a537b22a6d959a52bf4952b1f
document type
citation
dois
  1. 10.1200/JCO.18.02079
electronic publication date
display
2019 Jun 3
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31157579
immutable id
pubmed:31157579@363034fbc311776b294e529540528e86dff0e83a537b22a6d959a52bf4952b1f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
24
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2105-2119
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2019 Aug 20;37(24):2095-2097. doi: 10.1200/JCO.19.01113.
    note
    Source null
    related pmid
    31157580
    relationship
    Comment in
outcomes validated
false
pmid
31157579
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
d027a53d326390768ab886d346ce63ba82eabfefadb0fa635bee2d9ad2a1ab96
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Aug 20
precision
day
year
2019
publication types
  1. Journal Article
  2. Research Support, U.S. Gov't, Non-P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31157579/
title
Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice